Chris Erickson
Solo GP · Denver, CO
Chris Erickson is a solo GP based in Denver, CO focused on Biotech & Pharma, investing at pre-seed, seed stage. Chris Erickson's most recent fund with a disclosed size, Range Technology Ventures Fund II, L.P., filed a $45M offering with the SEC in Jul 2023. Estimated typical check: $450K–$1.35M. Chris Erickson has dated investing activity in the last 12 months (latest Nov 2025).
Why Chris Erickson is listed
Named as one of two individuals (Managing Director of the General Partner) on the Form D for Range Technology Ventures Fund II, L.P., a $45M venture fund (Jul 2023). Also a non-executive director at 3 startups that filed Form D.
Source: SEC Form D: Range Technology Ventures Fund II, L.P. (Jul 25, 2023) · 3 more sources
Is this you? Remove or correct this profile.
- Stages
- Pre-seed, Seed
- Typical check (est.)
- $450K–$1.35M
- Latest fund
- $45M · Jul 2023
- Latest dated activity
- Nov 2025
Is Chris Erickson a fit for you?
See your fit score and the reason, contact details, and any warm path from your network.
What does Chris Erickson invest in?
Biotech & PharmaWhat has Chris Erickson invested in recently?
- Nov 2025
Jawa Ventures
Board seat on the company's SEC filing (not by itself proof of an investment) · CO
- Mar 2025
Cime Therapeutics
Board seat on the company's SEC filing (not by itself proof of an investment) · CO
- Dec 2024
Motion.io
Board seat on the company's SEC filing (not by itself proof of an investment) · CO
- Jul 2023
Range Technology Ventures Fund II, L.P.
Invested through a fund
Funds and deal vehicles Chris Erickson filed with the SEC
- Jul 2023
Range Technology Ventures Fund II, L.P.
Fund · $45M offering
Sources
- SEC Form D: Range Technology Ventures Fund II, L.P.Jul 25, 2023
- SEC Form D (board seat): Motion.ioDec 18, 2024
- SEC Form D (board seat): Cime TherapeuticsMar 21, 2025
- SEC Form D (board seat): Jawa VenturesNov 5, 2025
Data refreshed from public sources Oct 15, 2026. Is this you? Remove or correct this profile.